The Differential Expression of Cide Family Members is Associated with Nafld Progression from Steatosis to...

Area of Science:

• Hepatology
• Molecular Biology
• Cell Death Research

Background:

• Non-Alcoholic Steatohepatitis (NAFLD) progression from simple steatosis requires understanding molecular drivers.
• Cell death-inducing DFF45 like effector (CIDE) proteins regulate hepatic lipid homeostasis and cell death.
• FSP27, a CIDE family member, plays a dual role in lipid metabolism and apoptosis.

Purpose of the Study:

• To investigate the role of CIDE proteins (CIDEA, FSP27α/β) in the progression of Non-Alcoholic Fatty Liver Disease (NAFLD).
• To examine the correlation between CIDE protein expression and liver injury in mouse models and human patients.
• To elucidate the functional impact of FSP27β on lipid droplet dynamics and apoptosis in hepatic cells.

Main Methods:

• Utilized dietary mouse models for hepatic steatosis and steatohepatitis.
• Analyzed hepatic CIDEA and FSP27 (α/β) expression in mouse models.
• Correlated human hepatic CIDEC2 (FSP27β homologue) and CIDEA expression with NAFLD activity scores in obese patients.
• Performed in vitro studies in hepatic cell lines involving FSP27β downregulation and overexpression.

Main Results:

• Hepatic CIDEA and FSP27α/β were upregulated in obesity-mediated steatosis.
• CIDEA decreased while FSP27-β significantly increased in steatohepatitis, showing an inverse pattern with disease severity.
• Human CIDEC2 expression strongly correlated with NAFLD activity score and liver injury; CIDEA expression varied with obesity and NAFLD severity.
• In vitro, FSP27β downregulation caused lipid droplet fractionation, while its overexpression reduced anti-apoptotic BCL2, sensitizing cells to apoptosis.

Conclusions:

• Differential expression of FSP27β/CIDEC2 and CIDEA is linked to NAFLD progression.
• FSP27β/CIDEC2 plays a critical role in promoting liver injury and apoptosis during NAFLD.
• Targeting CIDE proteins may offer therapeutic strategies for NAFLD.